Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Libra

Showing results (251-260 of 280) with videos related to

Pageof 28
Sort By:
Oncotarget|June 17, 2014
GSK-3 as potential target for therapeutic intervention in cancerJames A McCubrey, Linda S Steelman, Fred E Bertrand, et al.
Current Pharmaceutical Design|March 8, 2012
Targeting the cancer initiating cell: the ultimate target for cancer therapyJames A McCubrey, Linda S Steelman, Stephen L Abrams, et al.
Annals of the New York Academy of Sciences|September 7, 2007
Role of the HLA class II: HCV-related disordersValli De Re, Laura Caggiari, Maria Paola Simula, et al.
Oncotarget|December 22, 2016
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cellsJames A McCubrey, Timothy L Fitzgerald, Li V Yang, et al.
Frontiers in Digital Health|March 27, 2026
Correction: Adopting machine learning to predict breast cancer patients adherence with lifestyle recommendations and quality of life outcomesAnna Crispo, Elisabetta Pagnano, Agnese Bonfigli, et al.
Oncotarget|September 26, 2012
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy responseJames A McCubrey, Linda S Steelman, William H Chappell, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|September 26, 2020
SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19Aristides Tsatsakis, Daniela Calina, Luca Falzone, et al.
Plos One|February 21, 2015
Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseasesValli De Re, Laura Caggiari, Mariangela De Zorzi, et al.
Frontiers in Digital Health|November 24, 2025
Adopting machine learning to predict breast cancer patients adherence with lifestyle recommendations and quality of life outcomesAnna Crispo, Maria Elisabetta Pagnano, Agnese Bonfigli, et al.
Aging|June 15, 2017
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAsJames A McCubrey, Kvin Lertpiriyapong, Linda S Steelman, et al.
Pageof 28

Showing results (251-260 of 280) with videos related to

Sort By:
Pageof 28
Oncotarget|June 17, 2014
GSK-3 as potential target for therapeutic intervention in cancerJames A McCubrey, Linda S Steelman, Fred E Bertrand, et al.
Current Pharmaceutical Design|March 8, 2012
Targeting the cancer initiating cell: the ultimate target for cancer therapyJames A McCubrey, Linda S Steelman, Stephen L Abrams, et al.
Annals of the New York Academy of Sciences|September 7, 2007
Role of the HLA class II: HCV-related disordersValli De Re, Laura Caggiari, Maria Paola Simula, et al.
Oncotarget|December 22, 2016
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cellsJames A McCubrey, Timothy L Fitzgerald, Li V Yang, et al.
Frontiers in Digital Health|March 27, 2026
Correction: Adopting machine learning to predict breast cancer patients adherence with lifestyle recommendations and quality of life outcomesAnna Crispo, Elisabetta Pagnano, Agnese Bonfigli, et al.
Oncotarget|September 26, 2012
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy responseJames A McCubrey, Linda S Steelman, William H Chappell, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|September 26, 2020
SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19Aristides Tsatsakis, Daniela Calina, Luca Falzone, et al.
Plos One|February 21, 2015
Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseasesValli De Re, Laura Caggiari, Mariangela De Zorzi, et al.
Frontiers in Digital Health|November 24, 2025
Adopting machine learning to predict breast cancer patients adherence with lifestyle recommendations and quality of life outcomesAnna Crispo, Maria Elisabetta Pagnano, Agnese Bonfigli, et al.
Aging|June 15, 2017
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAsJames A McCubrey, Kvin Lertpiriyapong, Linda S Steelman, et al.
Pageof 28